2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

Europace

Volumn 15, Issue 8, 2013, Pages 1070-1118

  Brignole, Michele ^a   Auricchio, Angelo ^b   Baron Esquivias, Gonzalo ^b   Bordachar, Pierre ^b   Boriani, Giuseppe ^a   Breithardt, Ole A ^b   Cleland, John ^b   Deharo, Jean Claude ^b   Delgado, Victoria ^b   Elliott, Perry M ^b   Gorenek, Bulent ^b   Israel, Carsten W ^b   Leclercq, Christophe ^b   Linde, Cecilia ^b   Mont, Lluís ^b   Padeletti, Luigi ^a   Sutton, Richard ^b   Vardas, Panos E ^b  

^a DEPARTMENT OF CARDIOLOGY   (Italy)

^b NONE

Author keywords

Atrial fibrillation; Cardiac pacing; Cardiac resynchronization therapy; Heart failure; Pacemaker; Syncope

Indexed keywords

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; CONFLICT OF INTEREST; FINANCIAL MANAGEMENT; HEALTH CARE INDUSTRY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART TRANSPLANTATION; HISTORY; HUMAN; LONG QT SYNDROME; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SINUS BRADYCARDIA; SINUS NODE DISEASE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84880937087     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut206     Document Type: Review

References (176)

1. Alboni P, Menozzi C, Brignole M, Paparella N, Gaggioli G, Lolli G et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: A randomized controlled trial. Circulation 1997;96:260-266
2. Healey JS, ToffWD,Lamas GA, Andersen HR, Thorpe KE, EllenbogenKAet al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: Meta-Analysis of randomized trials, using individual patient data. Circulation 2006; 114:11-17
3. Nielsen JC, Thomsen PE, Hojberg S, Moller M, Vesterlund T, Dalsgaard D et al. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J 2011;32:686-696
4. Brignole M, Deharo JC, De Roy L, Menozzi C, BlommaertD, Dabiri L et al. Syncope due to idiopathic paroxysmal atrioventricular block: Long-Term follow-Up of a distinct form of atrioventricular block. J Am Coll Cardiol 2011;58:167-173
5. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, WielingWet al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 2006; 27:1085-1092
6. Breivik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent pacemaker in 109 patients. A follow-Up study. Acta Med Scand 1979;206: 153-159
7. Hartel G, Talvensaari T. Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients. Acta Med Scand 1975;198:341-347
8. Rasmussen K. Chronic sinus node disease: Natural course and indications for pacing. Eur Heart J 1981;2:455-459
9. Sasaki Y, Shimotori M, Akahane K, YonekuraH, Hirano K, Endoh R et al. Long-Term follow-Up of patients with sick sinus syndrome: A comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. Pacing Clin Electrophysiol 1988;11:1575-1583
10. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344:1523-1528
11. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, GillisAMet al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000;342:1385-1391
12. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854-1862
13. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 1998;338:1097-1104
14. Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005;353:145-155
15. Castelnuovo E, Stein K, Pitt M, Garside R, Payne E. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: Systematic review and economic evaluation. Health Technol Assess 2005;9:iii, xi-xiii, 1-246
16. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007;357:1000-1008
17. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al. Dualchamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123
18. Sud S, Klein GJ, Skanes AC, Gula LJ, Yee R, Krahn AD. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Europace 2007;9:312-318
19. Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): A randomized trial. Circulation 2012;125:2566-2571
20. Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: A multicenter, randomized, controlled trial. Circulation 2001;104:52-57
21. Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS).Arandomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20
22. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): A randomized trial. JAMA 2003;289:2224-2229
23. Raviele A, Giada F, Menozzi C, Speca G, Orazi S, Gasparini G et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 2004;25:1741-1748
24. Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardio-inhibitory syncope: Pacemaker versus no therapy: A multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000;102:294-299
25. Moya A, Garcia-CiveraR, Croci F, Menozzi C, Brugada J, Ammirati F et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J 2011;32:1535-1541
26. ScheinmanMM, PetersRW, Suave MJ, Desai J, Abbott JA, Cogan J et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982;50:1316-1322
27. Gronda M, Magnani A, Occhetta E, Sauro G, D'Aulerio M, Carfora A et al. Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications. G Ital Cardiol 1984;14:768-773
28. Bergfeldt L, Edvardsson N, Rosenqvist M, Vallin H, Edhag O. Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia-detecting pacemaker.Am J Cardiol 1994;74:1129-1132
29. Dini P, Iaolongo D, Adinolfi E et al. Prognostic value of His-ventricular conduction after ajmaline administration. In: Masoni A, Albani P (eds). Cardiac Electrophysiology Today. London: Academic Press; 1982, 515-522
30. Kaul U, Dev V, Narula J, Malhotra AK, Talwar KK, Bhatia ML. Evaluation of patients with bundle branch block and 'unexplained' syncope: A study based on comprehensive electrophysiological testing and ajmaline stress. Pacing Clin Electrophysiol 1988; 11:289-297
31. Twidale N, Heddle WF, Tonkin AM. Procainamide administration during electrophysiology study-Utility as a provocative test for intermittent atrioventricular block. Pacing Clin Electrophysiol 1988;11:1388-1397
32. Santini M, Castro A, Giada F, Ricci R, Inama G, Gaggioli G et al. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: The PRESS study. Circ Arrhythm Electrophysiol 2013; 6:101-107
33. McAnulty JH, Rahimtoola SH, Murphy E, DeMots H, Ritzmann L, Kanarek PE et al. Natural history of 'high-risk' bundle-branch block: Final report of a prospective study. N Engl J Med 1982;307:137-143
34. PetersRW, Scheinman MM, Modin C, O'Young J, Somelofski CA, Mies C. Prophylactic permanent pacemakers for patients with chronic bundle branch block. Am J Med 1979;66:978-985
35. Brignole M, Menozzi C. The natural history of carotid sinus syncope and the effect of cardiac pacing. Europace 2011;13:462-464
36. Brignole M,Menozzi C, Lolli G, BottoniN, Gaggioli G. Long-Term outcomeof paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol 1992;69: 1039-1043
37. Claesson JE, Kristensson BE, Edvardsson N,Wahrborg P. Less syncope and milder symptoms in patients treated with pacing for induced cardio-inhibitory carotid sinus syndrome: A randomized study. Europace 2007;9:932-936
38. Sugrue DD, Gersh BJ, Holmes DR Jr.,Wood DL, Osborn MJ, Hammill SC. Symptomatic 'isolated' carotid sinus hypersensitivity: Natural history and results of treatment with anticholinergic drugs or pacemaker. J Am Coll Cardiol 1986;7:158-162
39. Gaggioli G, Brignole M, Menozzi C, Devoto G, Oddone D, Gianfranchi L et al. A positive response to head-Up tilt testing predicts syncopal recurrence in carotid sinus syndrome patients with permanent pacemakers. Am J Cardiol 1995;76: 720-722
40. Maggi R, Menozzi C, Brignole M, Podoleanu C, Iori M, Sutton R et al. Cardio-inhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally mediated syncope. Europace 2007;9:563-567
41. MadiganNP, Flaker GC, Curtis JJ, Reid J, Mueller KJ, Murphy TJ. Carotid sinus hypersensitivity: Beneficial effects of dual-chamber pacing. Am J Cardiol 1984;53: 1034-1040
42. Brignole M, Sartore B, Barra M, Menozzi C, Lolli G. Is DDD superior to VVI pacing in mixed carotid sinus syndrome? An acute and medium-Term study. Pacing Clin Electrophysiol 1988;11:1902-1910
43. Sutton R. Pacing in patients with carotid sinus and vasovagal syndromes. Pacing Clin Electrophysiol 1989;12:1260-1263
44. Flammang D, ChurchTR,DeRoyL, Blanc JJ, Leroy J, MairesseGHet al. Treatmentof unexplained syncope: A multicenter, randomized trial of cardiac pacing guided by adenosine 5'-Triphosphate testing. Circulation 2012;125:31-36
45. Parry SW, Steen N, Bexton RS, Tynan M, Kenny RA. Pacing in elderly recurrent fallers with carotid sinus hypersensitivity: A randomised, double-blind, placebo controlled crossover trial. Heart 2009;95:405-409
46. Cleland JG, Freemantle N, Erdmann E, Gras D, Kappenberger L, Tavazzi L et al. Long-Term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail 2012;14: 628-634
47. Bogale N, Witte K, Priori S, Cleland J, Auricchio A, Gadler F et al. The European Cardiac Resynchronization Therapy Survey: Comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Eur J Heart Fail 2011;13:974-983
48. ZarebaW, Klein H, Cygankiewicz I, Hall WJ, McNitt S, BrownMet al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;123:1061-1072
49. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853
50. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338
51. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier ARet al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109-2116
52. Cazeau S, Leclercq C, Lavergne T,Walker S, Varma C, LindeCet al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880
53. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-1459
54. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289: 2685-2694
55. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
56. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549
57. Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-Analysis: Cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med 2011;154:401-412
58. Sipahi I, Carrigan TP, RowlandDY, Stambler BS, Fang JC. Impact ofQRSduration on clinical event reduction with cardiac resynchronization therapy: Meta-Analysis of randomized controlled trials. Arch Intern Med 2011;171:1454-1462
59. Gervais R, Leclercq C, Shankar A, Jacobs S, Eiskjaer H, Johannessen A et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: A sub-Analysis of the CARE-HF trial. Eur J Heart Fail 2009;11:699-705
60. AbrahamWT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-2868
61. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-1843
62. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Cardiac-resynchronization therapy for mild-To-moderate heart failure. N Engl J Med 2010;363:2385-2395
63. Gold MR, Thebault C, Linde C, AbrahamWT, Gerritse B, Ghio S et al. Effect ofQRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: Results from the Resynchronization Reverses Remodelling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation 2012;126:822-829
64. Sipahi I, Chou JC, Hyden M, Rowland DY, Simon DI, Fang JC. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-Analysis of randomized controlled trials.AmHeart J 2012;163:260-267 e263
65. Beshai JF, Grimm RA, Nagueh SF, Baker JH 2nd, Beau SL, Greenberg SM et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007;357:2461-2471
66. Thibault B, Harel F, Ducharme A, White M, Ellenbogen KA, Frasure-Smith N et al., LESSER-EARTH Investigators. Cardiac Resynchronization Therapy in Patients With Heart Failure and a QRS Complex, 120 Milliseconds: The Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) Trial. Circulation 2013;127:873-881
67. Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: Is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 2009;53:355-360
68. Hayes DL, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Seth M et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011;8:1469-1475
69. Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resynchronization therapy pacing: Insights from 32 844 patients. Circ Arrhythm Electrophysiol 2012;5: 884-888
70. Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G et al. Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol 2009;20:764-768
71. Thebault C, Donal E, Meunier C, Gervais R, Gerritse B, Gold MR et al. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J 2012;33:2662-2671
72. Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159-1166
73. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: The TARGET study: A randomized, controlled trial. J Am Coll Cardiol 2012;59: 1509-1518
74. Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm 2004;1:562-567
75. Vidal B, Tamborero D, Mont L, Sitges M, Delgado V, Berruezo A et al. Electrocardiographic optimization of interventricular delay in cardiac resynchronization therapy: A simple method to optimize the device. J Cardiovasc Electrophysiol 2007; 18:1252-1257
76. AbrahamWT, Calò L, Islam N, Klein N, Alawwa A, ExnerDet al. Randomized controlled trial of frequent optimization of cardiac resynchronization therapy: Results of the Frequent Optimization Study Using the QuickOptTM Method (FREEDOM) Trial. (in press
77. Abraham WT, Leon AR, St John Sutton MG, Keteyian SJ, Fieberg AM, Chinchoy E et al. Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy. Am Heart J 2012;164:735-741
78. Boriani G, Muller CP, Seidl KH, Grove R, Vogt J, Danschel W et al. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Am Heart J 2006;151:1050-1058
79. Ellenbogen KA, Gold MR, Meyer TE, Fernndez Lozano I, Mittal S, Waggoner AD et al. Primary results from the SmartDelay determined AVoptimization: A comparison with other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiographyguided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation 2010;122:2660-2668
80. Leon AR, AbrahamWT, Brozena S, Daubert JP, FisherWG,Gurley JC et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-To-severe heart failure. J Am Coll Cardiol 2005;46:2298-2304
81. Martin DO, Lemke B, Birnie D, Krum H, Lee KL, Aonuma K et al. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: Results of the adaptive CRT trial. Heart Rhythm 2012;9:1807-1814
82. Rao RK, Kumar UN, Schafer J, Viloria E, De Lurgio D, Foster E. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: A randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation 2007;115:2136-2144
83. Ritter P, Delnoy PP, Padeletti L, Lunati M, Naegele H, Borri-Brunetto A et al. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace 2012;14:1324-1333
84. Gasparini M, Bocchiardo M, Lunati M, Ravazzi PA, Santini M, Zardini M et al. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: The Bi vs. Left Ventricular Pacing: An International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J 2006;152:155 e151-e157
85. Boriani G, KranigW, Donal E, Calo L, Casella M, Delarche N et al. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: The Biventricular versus Left Univentricular Pacing with ICD Back-Up in Heart Failure Patients (B-LEFT HF) trial. Am Heart J 2010;159:1052-1058 e1051
86. Liang Y, PanW, Su Y, Ge J. Meta-Analysis of randomized controlled trials comparing isolated left ventricular and biventricular pacing in patients with chronic heart failure. Am J Cardiol 2011;108:1160-1165
87. Thibault B, Ducharme A, Harel F, White M, O'Meara E, Guertin MCet al. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ./120 milliseconds. Circulation 2011;124:2874-2881
88. Boriani G, Gardini B, Diemberger I, Bacchi Reggiani ML, Biffi M, Martignani C et al. Meta-Analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: Effect on all-cause mortality and hospitalizations. Eur J Heart Fail 2012;14:652-660
89. Brignole M, Botto G, Mont L, Iacopino S, De Marchi G, Oddone D et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: A randomized trial. Eur Heart J 2011;32:2420-2429
90. Leclercq C,Walker S, Linde C, Clementy J, Marshall AJ, Ritter P et al. Comparative effects of permanent biventricular and right-Univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-1787
91. Upadhyay GA, Choudhry NK, Auricchio A, Ruskin J, Singh JP. Cardiac resynchronization in patients with atrial fibrillation: A meta-Analysis of prospective cohort studies. J Am Coll Cardiol 2008;52:1239-1246
92. Wilton SB, Leung AA, Ghali WA, Faris P, Exner DV. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and meta-Analysis. Heart Rhythm 2011;8:1088-1094
93. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S et al. Long-Term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40: 111-118
94. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-1165
95. Wein S, Voskoboinik A, Wein L, Billah B, Krum H. Extending the boundaries of cardiac resynchronization therapy: Efficacy in atrial fibrillation, New York Heart Association class II, and narrow QRS heart failure patients. J Card Fail 2010;16: 432-438
96. Kamath GS, Cotiga D, Koneru JN, Arshad A, PierceW, Aziz EF et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J Am Coll Cardiol 2009;53:1050-1055
97. Tolosana JM, Hernandez Madrid A, Brugada J, Sitges M, Garcia Bolao I, Fernandez Lozano I et al. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study). Am J Cardiol 2008;102:444-449
98. Ferreira AM, Adragao P, Cavaco DM, Candeias R, Morgado FB, Santos KR et al. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: The role of atrioventricular junction ablation. Europace 2008;10: 809-815
99. Ganesan AN, Brooks AG, Roberts-Thomson KC, Lau DH, Kalman JM, Sanders P. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 2012;59: 719-726
100. Gasparini M, Auricchio A, Metra M, Regoli F, Fantoni C, Lamp B et al. Long-Term survival in patients undergoing cardiac resynchronization therapy: The importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008;29:1644-1652
101. GaspariniM, Auricchio A, Regoli F, Fantoni C, Kawabata M, Galimberti P et al. Fouryear efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: The importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006;48:734-743
102. Molhoek SG, Bax JJ, Bleeker GB, Boersma E, van Erven L, Steendijk P et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004;94:1506-1509
103. Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 2007;99:1252-1257
104. Khadjooi K, FoleyPW, Chalil S, Anthony J, Smith RE, FrenneauxMPet al. Long-Term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart 2008;94:879-883
105. Orlov MV, Gardin JM, Slawsky M, Bess RL, Cohen G, BaileyWet al. Biventricular pacing improves cardiac function and prevents further left atrial remodelling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J 2010;159:264-270
106. Brignole M, Gammage M, Puggioni E, Alboni P, Raviele A, Sutton R et al. Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation. Eur Heart J 2005;26:712-722
107. Brignole M, Botto GL, Mont L, Oddone D, Iacopino S, De MarchiGet al. Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation. Heart 2012;98:297-302
108. Leclercq C, Cazeau S, Lellouche D, Fossati F, Anselme F, Davy JM et al. Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study. Pacing Clin Electrophysiol 2007;30 Suppl 1:S23-30
109. Delnoy PP, Ottervanger JP, VosDH, Elvan A, Misier AR, BeukemaWPet al. Upgrading to biventricular pacing guided by pressure-volume loop analysis during implantation. J Cardiovasc Electrophysiol 2011;22:677-683
110. Hoijer CJ, Meurling C, Brandt J. Upgrade to biventricular pacing in patients with conventional pacemakers and heart failure: A double-blind, randomized crossover study. Europace 2006;8:51-55
111. van Geldorp IE, Vernooy K, Delhaas T, Prins MH, Crijns HJ, PrinzenFWet al. Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace 2010;12:223-229
112. BakerCM,Christopher TJ, Smith PF, Langberg JJ, Delurgio DB, Leon AR. Addition of a left ventricular lead to conventional pacing systems in patients with congestive heart failure: Feasibility, safety, and early results in 60 consecutive patients. Pacing Clin Electrophysiol 2002;25:1166-1171
113. Eldadah ZA, Rosen B, Hay I, Edvardsen T, Jayam V, Dickfeld T et al. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging. Heart Rhythm 2006;3:435-442
114. Laurenzi F, Achilli A, Avella A, Peraldo C, Orazi S, Perego GB et al. Biventricular upgrading in patients with conventional pacing system and congestive heart failure: Results and response predictors. Pacing Clin Electrophysiol 2007;30:1096-1104
115. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258-1263
116. Shimano M, Tsuji Y, Yoshida Y, Inden Y, Tsuboi N, Itoh T et al. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with longterm pacemaker therapy for acquired complete atrioventricular block. Europace 2007;9:869-874
117. Valls-Bertault V, Fatemi M, Gilard M, Pennec PY, Etienne Y, Blanc JJ. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace 2004;6:438-443
118. Vatankulu MA, Goktekin O, Kaya MG, Ayhan S, Kucukdurmaz Z, Sutton R et al. Effect of long-Term resynchronization therapy on left ventricular remodelling in pacemaker patients upgraded to biventricular devices. Am J Cardiol 2009;103: 1280-1284
119. Foley PW, Muhyaldeen SA, Chalil S, Smith RE, Sanderson JE, Leyva F. Long-Term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Europace 2009;11:495-501
120. Frohlich G, Steffel J, Hurlimann D, Enseleit F, Luscher TF, Ruschitzka F et al. Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. Eur Heart J 2010;31:1477-1485
121. Marai I, Gurevitz O, Carasso S, Nof E, Bar-Lev D, LuriaDet al. Improvement of congestive heart failure by upgrading of conventional to resynchronization pacemakers. Pacing Clin Electrophysiol 2006;29:880-884
122. Paparella G, Sciarra L, Capulzini L, Francesconi A, De Asmundis C, Sarkozy A et al. Long-Term effects of upgrading to biventricular pacing: Differences with cardiac resynchronization therapy as primary indication. Pacing Clin Electrophysiol 2010; 33:841-849
123. Albertsen AE, Nielsen JC, Poulsen SH, MortensenPT, Pedersen AK, Hansen PS et al. Biventricular pacing preserves left ventricular performance in patients with highgrade atrio-ventricular block: A randomized comparison with DDD(R) pacing in 50 consecutive patients. Europace 2008;10:314-320
124. Chan JY, Fang F, Zhang Q, Fung JW, Razali O, Azlan H et al. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J 2011;32:2533-2540
125. Curtis AB, Worley S Adamson PB, Chung E, Niazi I, Sherfesee L, Shinn Tet al. Biventricular pacing for atrioventricular block and systolic dysfunction. New Engl J Med 2013;368:1585-1593
126. Curtis AB, Adamson PB, Chung E, Sutton MS, Tang F,Worley S. Biventricular versus right ventricular pacing in patients with AV block (BLOCKHF): Clinical study design and rationale. J Cardiovasc Electrophysiol 2007;18:965-971
127. Kindermann M, Hennen B, Jung J, Geisel J, Bohm M, Frohlig G. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: The Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927-1937
128. Martinelli Filho M, de Siqueira SF, Costa R, Greco OT, Moreira LF, D'Avila A et al. Conventional versus biventricular pacing in heart failure and bradyarrhythmia: The COMBAT study. J Card Fail 2010;16:293-300
129. Stockburger M, Gomez-Doblas JJ, Lamas G, Alzueta J, Fernandez-Lozano I, Cobo E et al. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: Results from a multi-centre international randomized trial (PREVENT-HF). Eur J Heart Fail 2011;13:633-641
130. Yu CM, Chan JY, Zhang Q, Omar R, YipGW, Hussin A et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009;361: 2123-2134
131. Lam SK, Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-Analysis of randomised controlled trials. BMJ 2007;335:925
132. Gang UJ, Hvelplund A, Pedersen S, Iversen A, Jons C, Abildstrom SZ et al. Highdegree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace 2012;14:1639-1645
133. Behar S, Zissman E, Zion M, Hod H, Goldbourt U, Reicher-ReissHet al. Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. SPRINT Study Group. Am J Cardiol 1993;72:831-834
134. Col JJ, Weinberg SL. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol 1972;29:344-350
135. Ginks WR, Sutton R, OhW, Leatham A. Long-Term prognosis after acute
136. Jim MH, Chan AO, Tse HF, Barold SS, Lau CP. Clinical and angiographic findings of complete atrioventricular block in acute inferior myocardial infarction. Ann Acad Med Singapore 2010;39:185-190
137. Gross GJ, Chiu CC, Hamilton RM, Kirsh JA, Stephenson EA. Natural history of postoperative heart block in congenital heart disease: Implications for pacing intervention. Heart Rhythm 2006;3:601-604
138. Krongrad E. Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation 1978;57:867-870
139. Murphy DA, Tynan M, Graham GR, Bonham-Carter RE. Prognosis of complete atrioventricular dissociation in children after open-heart surgery. Lancet 1970;1: 750-752
140. Squarcia U, Merideth J, McGoon DC, Weidman WH. Prognosis of transient atrioventricular conduction disturbances complicating open heart surgery for congenital heart defects. Am J Cardiol 1971;28:648-652
141. Weindling SN, Saul JP, Gamble WJ, Mayer JE, Wessel D, Walsh EP. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol 1998;82:525-527
142. Chang SM, Nagueh SF, SpencerWH3rd, LakkisNM. Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 2003;42: 296-300
143. Topilski I, Sherez J, Keren G, Copperman I. Long-Term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy .50 years of age. Am J Cardiol 2006;97:1769-1775
144. Kappenberger L, Linde C, Daubert C, McKennaW, Meisel E, SadoulNet al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J 1997;18:1249-1256
145. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999;99:2927-2933
146. Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN et al. Dualchamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29:435-441
147. Galve E, Sambola A, Saldana G, Quispe I, Nieto E, Diaz A et al. Late benefits of dualchamber pacing in obstructive hypertrophic cardiomyopathy: A 10-year follow-Up study. Heart 2010;96:352-356
148. Megevand A, Ingles J, Richmond DR, Semsarian C. Long-Term follow-Up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. Am J Cardiol 2005;95:991-993
149. IsraelCW, Hugl B, Unterberg C,LawoT,Kennis I, HettrickDet al. Pace-Termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-1128
150. Blanc JJ, De Roy L, Mansourati J, Poezevara Y, Marcon JL, Schoels Wet al. Atrial pacing for prevention of atrial fibrillation: Assessment of simultaneously implemented algorithms. Europace 2004;6:371-379
151. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P et al. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-633
152. Gold MR, Adler S, Fauchier L, Haffajee C, Ip J, KainzWet al. Impact of atrial prevention pacing on atrial fibrillation burden: Primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 2009;6:295-301
153. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366: 120-129
154. Hohnloser SH, Healey JS, Gold MR, Israel CW, Yang S, van Gelder I et al. Atrial overdrive pacing to prevent atrial fibrillation: Insights from ASSERT. Heart Rhythm 2012;9:1667-1673
155. IsraelCW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Prevention of immediate reinitiation of atrial tachyarrhythmias by high-rate overdrive pacing: Results from a prospective randomized trial. J Cardiovasc Electrophysiol 2003;14:954-959
156. Kantharia BK, Freedman RA, Hoekenga D, Tomassoni G,Worley S, Sorrentino R et al. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: Insights from the Atrial Overdrive Pacing Study. Europace 2007;9:1024-1030
157. Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J AmColl Cardiol 2003;41:1926-1932
158. Mont L, Ruiz-Granell R, Martinez JG, Carmona JR, Fidalgo M, Cobo E et al. Impact of anti-Tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: Results of the prevention or termination(POT) trial. Europace 2008;10:28-34
159. Sulke N, Silberbauer J, Boodhoo L, Freemantle N, Kamalvand K, O'Nunain S et al. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: The Pacemaker Atrial Fibrillation Suppression (PAFS) study. Europace 2007;9:790-797
160. Burke PT, Ghanbari H, Alexander PB, Shaw MK, Daccarett M, Machado C. A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): Should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol 2010;28:59-66
161. Del Ojo JL, Moya F, Villalba J, Sanz O, Pavon R, GarciaDet al. Is magnetic resonance imaging safe in cardiac pacemaker recipients? Pacing Clin Electrophysiol 2005;28: 274-278
162. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol 2005;28:270-273
163. HalshtokO, Goitein O, Abu Sham'a R, Granit H, Glikson M, Konen E. Pacemakers and magnetic resonance imaging: No longer an absolute contra-indication when scanned correctly. Isr Med Assoc J 2010;12:391-395
164. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315-1324
165. Mollerus M, Albin G, Lipinski M, Lucca J. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol 2008;31:1241-1245
166. MollerusM, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 2010;12:947-951
167. Naehle CP, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H et al. Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: Pilot prospective study with 51 examinations. Radiology 2008;249: 991-1001
168. Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009;54:549-555
169. Naehle CP, Zeijlemaker V, Thomas D, Meyer C, Strach K, Fimmers R et al. Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol 2009;32:1526-1535
170. Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo ACet al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011;155:415-424
171. Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: A prospective study with 115 examinations. Circulation 2006;114:1285-1292
172. Strach K, Naehle CP, Muhlsteffen A, Hinz M, Bernstein A, ThomasDet al. Low-field magnetic resonance imaging: Increased safety for pacemaker patients? Europace 2010;12:952-960
173. Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, HeuerHet al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011;8:65-73
174. Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: The value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 2011;57:1181-1189
175. Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012;125:2985-2992
176. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial. Circulation 2010;122:325-332